Precision BioSciences, Inc.
FUNCTION-DMD
DMD
Resolved
98days ago
Phase 1 readout Β· ~ Mar 31, 2026 estimated
What's at stake
Phase 1 trial results for FUNCTION-DMD in DMD are due ~ Mar 31, 2026. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
Β· SEC 8-K
verified 15h ago
βPending clearance of the investigational new drug application, the FUNCTION-DMD Phase 1/2 clinical trial in Duchenne muscular dystrophy patients is expected to dose the first patient in late-Q1 or early-Q2 2026.β